The Enterprise Value as of December 2025 (TTM) for Esperion Therapeutics, Inc. (0IIM.L) is 831.55M

According to Esperion Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 831.55M. This represents a change of 42.21% compared to the average of 584.72M of the last 4 quarters.

Esperion Therapeutics, Inc. (0IIM.L) Historical Enterprise Value (quarterly & annually)

How has 0IIM.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Esperion Therapeutics, Inc. over the last ten years is 781.65M. The current 831.55M Enterprise Value has changed 10.54% with respect to the historical average. Over the past ten years (40 quarters), 0IIM.L's Enterprise Value was at its highest in in the March 2018 quarter at 1.89B. The Enterprise Value was at its lowest in in the June 2016 quarter at 177.47M.

Esperion Therapeutics, Inc. (0IIM.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Esperion Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Esperion Therapeutics, Inc. (0IIM.L) Average Enterprise Value

How has 0IIM.L Enterprise Value performed in the past?

The current Enterprise Value of Esperion Therapeutics, Inc. (0IIM.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Esperion Therapeutics, Inc. (0IIM.L) Enterprise Value vs. Peers

How is 0IIM.L’s Enterprise Value compared to its peers?

Esperion Therapeutics, Inc.’s Enterprise Value is less than Emergent BioSolutions Inc. (1.06B), greater than Verastem, Inc. (540.91M), greater than Iovance Biotherapeutics, Inc. (686.90M), greater than Anavex Life Sciences Corp. (286.61M), less than Geron Corporation (854.51M), greater than Sangamo Therapeutics, Inc. (154.74M), greater than Myriad Genetics, Inc. (739.16M), greater than Heron Therapeutics, Inc. (373.45M), greater than Editas Medicine, Inc. (145.22M), greater than Aclaris Therapeutics, Inc. (332.34M),

Build a custom stock screener for Esperion Therapeutics, Inc. (0IIM.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Esperion Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Esperion Therapeutics, Inc. (0IIM.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Esperion Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.